3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neuroblastoma
5
Medulloblastoma
5
Carcinoma
4
Mouth Neoplasms
3
Laryngeal Neoplasms
3
Hypopharyngeal Neoplasms
3
Ganglioneuroblastoma
3
Vulvar Neoplasms
2
Stomach Neoplasms
2
Oropharyngeal Neoplasms
2
Gallbladder Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Vomiting
1
Urinary Bladder Neoplasms
1
Teratoma
1
Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7
1
Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7
1
Sertoli-Leydig Cell Tumor
1
Rhabdoid Tumor
1
Recurrent Uterine Corpus Carcinoma
1
Papillomavirus Infections
1
Ovarian gynandroblastoma
1
Ovarian Neoplasms
1
Osteosarcoma
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Nausea
1
Lymphoid Interstitial Pneumonia
1
Interventions
Fluorouracil
8
Cisplatin
5
Radiotherapy
4
Mitomycin
4
Light Coagulation
3
dehydroftorafur
2
Watchful Waiting
2
Taxes
2
Radiotherapy, Intensity-Modulated
2
Paclitaxel
2
Cetuximab
2
Carboplatin
2
Capecitabine
2
Biopsy
2
Vorinostat
1
Specimen Handling
1
Polymerase Chain Reaction
1
Platinum
1
Octreotide
1
Observation
1
Mitozytrex
1
Magnetic Resonance Spectroscopy
1
Laser Therapy
1
Imiquimod
1
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
1
Gene Expression Profiling
1
Fluorodeoxyglucose F18
1
DNA Methylation
1
Cidofovir
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Anus Neoplasms
×
Platinum
×
Clear all
NCT02560298
2023-06-22
InterAACT
Eastern Cooperative Oncology Group
Phase 2
Unknown
91 enrolled